Get 30% off on all global market reports with code ONLINE30 – stay updated on tariff changes, macroeconomic trends, and more!
Hepatorenal Syndrome Treatment Industry Expansion: How the Market Size Has Grown Over the Last 5 Years?
In recent times, the hepatorenal syndrome treatment market has seen consistent growth. The market size, which is projected to be at $14.49 billion in 2024, is expected to increase to $15.17 billion in 2025, indicating a compound annual growth rate (CAGR) of 4.6%.
Factors contributing to this growth during the past period include the expansion of the automotive industry, needs within the aerospace sector, benefits from material utilization, enhancements in mechanical features, adherence to strict industry standards, as well as increases in efficiency and precision.
The market for hepatorenal syndrome treatment is predicted to witness robust growth in the forthcoming years. This market is projected to expand to $19.57 billion by 2029, with a compound annual growth rate (CAGR) of 6.6%.
The growth during this period can be attributed to an increase in renewable energy projects, a surge in demand for high-performance alloys, focus on sustainable manufacturing, and expansion in oil and gas exploration, alongside a demand for high-performance components. Key trends for this forecast period encompass the inclusion of industry 4.0 techniques, advancements in forging technique research, customisation for precise applications, the introduction of automation in forging operations, and novel developments in heating and cooling technologies.
Claim Your Free Sample Report:
http://www.thebusinessresearchcompany.com/sample….p;type=smp
What Growth Drivers Are Responsible for Accelerating Hepatorenal Syndrome Treatment Market Growth?
The hepatorenal syndrome treatment market is anticipated to grow due to the rising cases of patients suffering from liver damage or cirrhosis. Cirrhosis, which is a severe type of liver disease where healthy liver tissue gets permanently replaced by scar tissue, compels the need for hepatorenal syndrome treatment.
The objective is to preserve the kidney function of the patient while easing the symptoms and residual impacts of the disease.
These treatment strategies could enhance the overall health of the patient, making them a suitable candidate for liver transplant surgery.
As per data unveiled by the British Liver Trust, a charity institution located in the UK, there was a 22% spike in hospital admissions due to liver disease in England in a single year, come July 2023. The total surged from 67,458 in 2021 to 82,290 in the fiscal year ending 2022.
Hence, this heightened prevalence of liver damage or cirrhosis is contributing to the expansion of the hepatorenal syndrome treatment market.
Performance of Leading Segments in the Hepatorenal Syndrome Treatment Global Market
The hepatorenal syndrome treatment market covered in this report is segmented –
1) By Type: Type 1 Hepatorenal Syndrome, Type 2 Hepatorenal Syndrome
2) By Treatment: Therapeutics, Surgical Treatment
3) By End-User: Hospitals And Clinics, Ambulatory Surgical Centers, Academic And Research Institutes, Other End-Users
Subsegments:
1) By Type 1 Hepatorenal Syndrome: Intravenous Albumin, Vasopressors, Dialysis, Liver Transplantation
2) By Type 2 Hepatorenal Syndrome: Albumin Infusion, Midodrine, Octreotide, Liver Transplantation
Access the Full Report Today:
http://www.thebusinessresearchcompany.com/report/…ket-report
What are the upcoming Trends Poised to Transform the Future of the Hepatorenal Syndrome Treatment Market?
The rise in research and development activities for the treatment of hepatorenal syndrome is becoming a significant trend in the hepatorenal syndrome treatment market. To sustain competition, companies in this market are directing their focus on more innovative research and development initiatives.
For example, Mallinckrodt Pharmaceuticals, a company based in Ireland that specializes in developing and distributing specialty products and therapies, received FDA approval for Terlivaz in September 2022, a treatment that aims to boost kidney function in adults suffering from hepatorenal syndrome. The FDA’s approval was strongly influenced by the Phase 3 CONFIRM trial, the most extensive prospective study (with 300 participants) ever conducted to assess the safety and efficacy of terlipressin in treating patients with HRS type 1 (HRS-1) in the U.S.
and Canada. The main objective of the CONFIRM trial, which was to demonstrate HRS Reversal, captured as an enhancement in renal function, negating the need for dialysis and improving short-term survival was accomplished (p=0.012).
What Are the Regional Hotspots for Hepatorenal Syndrome Treatment Market Growth?
North America was the largest region in the hepatorenal syndrome treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global hepatorenal syndrome treatment market during the forecast period.
The regions covered in the hepatorenal syndrome treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Get a Customized Version of the Report:
http://www.thebusinessresearchcompany.com/customi…p;type=smp
Which Companies Hold the Largest Market Share in the Hepatorenal Syndrome Treatment Industry?
Major companies operating in the hepatorenal syndrome treatment market include BioVie Inc., Cumberland Pharmaceuticals Inc., Mallinckrodt Pharmaceuticals, Orphan Therapeutics LLC, Baxter International Inc., La Jolla Pharmaceutical Company, Noorik Biopharmaceuticals AG, Novartis AG, Zydus Lifesciences Limited, Ocelot Bio Inc., New Medicon Pharma Lab Private Limited, Arrowhead Pharmaceuticals, Stealth BioTherapeutics Inc., Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Vertex Pharmaceuticals Inc., Johnson & Johnson, Boehringer Ingelheim GmbH, Catalyst Pharmaceuticals Inc., Bayer AG, Gilead Sciences Inc.
Access the Complete Report:
http://www.thebusinessresearchcompany.com/purchas…x?id=10414
How Our Market Research Reports Help Maximize ROI Across Industries:
* Identify High-Growth Opportunities: Pinpoint emerging trends, untapped segments, and regional hotspots that align with your strategic goals.
* Reduce Investment Risk: Make data-driven decisions with confidence by understanding market dynamics, key drivers, and competitive threats.
* Optimize Strategic Planning: Align your product development, marketing, and expansion plans with industry forecasts and customer behaviour insights.
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
News From
The Business Research Company …
Category: Industry Reports & Market Analysis Profile: The Business Research Company is a leading market research and consulting services provider. It offers over 9,500 market reports across 27 industries in 60+ geographies, providing detailed insights and forecasts. Its customised research solutions support companies in making critical decisions, while its continuous research service enhances organizational capabilities. The flagship Global Market Model database provides comprehensive market intelligence with 1,500,000 datasets covering 8,000+ mark …
This email address is being protected from spambots. You need JavaScript enabled to view it.
